Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons

Sexually Transmitted Diseases

Volumn 28, Issue 6, 2001, Pages 343-346

  Matteelli, Alberto ^a   Beltrame, Anna ^a   Graifemberghi, Severo ^a   Forleo, Maria Antonietta ^a   Gulletta, Maurizio ^a   Ciravolo, Giuseppe ^a   Tedoldi, Simona ^a   Casalini, Catia ^a   Carosi, Giampiero ^a  

^a Clin of Infect and Trop Diseases   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; PLACEBO;

ADULT; ANUS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; EROSION; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; MALE; MUCOSA INFLAMMATION; PAIN; PENIS; PERINEUM; PILOT STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SEXUALLY TRANSMITTED DISEASE; SINGLE BLIND PROCEDURE; SKIN IRRITATION; TREATMENT OUTCOME; VERRUCA VULGARIS; VULVA; WART VIRUS;

EID: 0035716840     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200106000-00007     Document Type: Article

References (15)

1. Global epidemiology of sexually transmitted diseases
2. Genital human papillomavirus infection
3. HIV, sexually transmitted diseases, and gynecologic disorders in women: Increased risk for genital herpes and warts among HIV-infected prostitutes in Amsterdam
4. External genital warts: Report of the American Medical Association consensus conference
5. Therapeutic potential of cidofovir (HPMPC, Vistide) for the treatment of DNA virus (e.g., herpes-, papova-, pox- and adenovirus) infection
6. A randomised, double-blind, controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS
7. Topical and intralesional cidofovir: A review of pharmacology and therapeutic affects
8. Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonomethoxy)-propyl]cytosine
9. Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue
10. A phase I/II study of cidofovir topical gel for refractory condyloma acuminatum in patients with HIV infection
11. Intralesional or topical cidofovir (HPMPC, vistide) for the treatment of recurrent genital warts in HIV-1 infected patients
12. Successful treatment of recalcitranl condyloma with topical cidofovir
13. A randomised, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV infected patients
14. Correlation between human immunodeficiency vires type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix
15. Human papillomavirus infection and associated disease in persons infected with human immunodeficiency virus